Serum HBV RNA levels are associated with risk of hepatitis flare after stopping NA therapy in HBeAg-negative patients

被引：0

作者：

Jackson, Kathy ^{[1
,2
]}

Visvanathan, Kumar ^{[3
,4
]}

Hall, Samuel ^{[3
,4
]}

Burns, Gareth ^{[5
]}

Bonanzinga, Sara ^{[1
,2
]}

Anagnostou, Despina ^{[3
,4
]}

Desmond, Paul ^{[3
,4
]}

Ratnam, Dilip ^{[6
]}

Sievert, William ^{[7
,8
]}

Levy, Miriam ^{[9
,10
]}

Nicoll, Amanda ^{[8
,11
]}

Lubel, John ^{[8
,12
]}

Angus, Peter ^{[13
,14
]}

Sinclair, Marie ^{[13
,14
]}

Strasser, Simone ^{[15
,16
]}

Ngu, Meng ^{[17
,18
]}

Meredith, Christopher ^{[19
]}

Matthews, Gail ^{[20
,21
]}

Revill, Peter ^{[1
,2
]}

Sundararajan, Vijaya ^{[22
]}

Vogrin, Sara ^{[3
,4
]}

Kuchta, Alison ^{[23
]}

Canchola, Jesse ^{[23
]}

Torres, Jason ^{[23
]}

Lau, Jasmine ^{[23
]}

Thompson, Alexander ^{[3
,4
]}

机构：

[1] Victorian Infect Dis Lab, Melbourne, Vic, Australia

[2] Doherty Inst, Melbourne, Vic, Australia

[3] St Vincents Hosp, Fitzroy, Vic, Australia

[4] Univ Melbourne, Gastroenterol, Fitzroy, Vic, Australia

[5] Western Hlth, Gastroenterol, Footscray, Vic, Australia

[6] Monash Hlth, Gastroenterol, Clayton, Vic, Australia

[7] Monash Hlth, Clayton, Vic, Australia

[8] Monash Univ, Clayton, Vic, Australia

[9] Liverpool Hosp, Liverpool, Merseyside, England

[10] UNSW, South Western Sydney Clin Sch, Sydney, NSW, Australia

[11] Eastern Hlth, Box Hill, Vic, Australia

[12] Alfred Hosp, Melbourne, Vic, Australia

[13] Austin Hosp, Heidelberg, Vic, Australia

[14] Univ Melbourne, Melbourne, Vic, Australia

[15] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[16] UNSW, Sydney, NSW, Australia

[17] Concord Hosp, Sydney, NSW, Australia

[18] Univ Sydney, Sydney, NSW, Australia

[19] Bankstown Lidcombe Hosp, Sydney, NSW, Australia

[20] UNSW, Kirby Inst, Sydney, NSW, Australia

[21] St Vincents Hosp Sydney, Sydney, NSW, Australia

[22] La Trobe Univ, Melbourne, Vic, Australia

[23] Roche Mol Syst Inc, Pleasanton, CA USA

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT377

引用

页码：S842 / S842

页数：1

共 50 条

[1] Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants
Thompson, Alexander J.
Jackson, Kathy
Bonanzinga, Sara
Hall, Sam A. L.
Hume, Simon
Burns, Gareth S.
Sundararajan, Vijaya
Ratnam, Dilip
Levy, Miriam T.
Lubel, John
Nicoll, Amanda J.
Strasser, Simone I.
Sievert, William
Desmond, Paul V.
Ngu, Meng C.
Sinclair, Marie
Meredith, Christopher
Matthews, Gail
Revill, Peter A.
Littlejohn, Margaret
Bowden, D. Scott
Canchola, Jesse A.
Torres, Jason
Siew, Philip
Lau, Jasmin
La Brot, Benjamin
Kuchta, Alison
Visvanathan, Kumar
HEPATOLOGY COMMUNICATIONS, 2023, 7 (08)
[2] COMMON HEPATITIS FLARE BUT RARE HBsAg SEROCLEARANCE AFTER STOPPING NA TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHB PATIENTS
Wong, Grace L.
Yuen, Becky W. Y.
Hui, Vicki Wing Ki
Tse, Yee-Kit
Yip, Terry Cheuk-Fung
Liang, Lilian Yan
Chan, Henry Lik Yuen
Wong, Vincent Wai-Sun
HEPATOLOGY, 2019, 70 : 299A - 300A
[3] Characterization of T cell responses after stopping HBV therapy with nucleos(t)ide analogues (NA) in HBeAg-negative patients
Rinker, Franziska
Zimmer, Christine L.
Siederdissen, Christoph Hoener Zu
Manns, Michael P.
Wedemeyer, Heiner
Kraft, Anke R.
Bjorkstrom, Niklas K.
Cornberg, Markus
HEPATOLOGY, 2016, 64 : 292A - 293A
[4] Evaluation of pregenomic HBV RNA in HBeAg-negative patients
Roncarati, Greta
Galli, Silvia
Ferniani, Tiziano
Moroni, Alessandra
Lazzarotto, Tiziana
NEW MICROBIOLOGICA, 2022, 45 (02): : 104 - 110
[5] PARTIALLY RESTORED T CELL RESPONSES IN HBEAG-NEGATIVE CHRONIC PATIENTS AFTER STOPPING NA THERAPY
Rinker, F.
zu Siederdissen, C. H.
Bremer, B.
Manns, M. P.
Wedemeyer, H.
Kraft, A. R. M.
Cornberg, M.
JOURNAL OF HEPATOLOGY, 2016, 64 : S388 - S389
[6] Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapy
Papatheodoridi, Margarita
Papachristou, Eleni
Moschidis, Zissis
Hadziyannis, Emilia
Rigopoulou, Eirini
Zachou, Kalliopi
Villeret, Francois
Magiorkinis, Gkikas
Lyberopoulou, Aggeliki
Gatselis, Nikolaos
Vlachogiannakos, Ioannis
Manolakopoulos, Spilios
Dalekos, George N.
Zoulim, Fabien
Paraskevis, Dimitrios
Papatheodoridis, George, V
JOURNAL OF VIRAL HEPATITIS, 2022, 29 (11) : 948 - 957
[7] Circulating hepatitis B virus RNA levels are associated with risk of hepatitis flare after stopping nucleos(t)ide analogue therapy in hepatitis B e-antigen-negative patients
Thompson, A. J.
Jackson, K.
Hall, S.
Hume, S.
Burns, G.
Mooney, B.
Millen, R.
Morris, R.
Vogrin, S.
Sundararajan, V.
Ratnam, D.
Levy, M.
Lubel, J.
Nicoll, A.
Strasser, S.
Sievert, W.
Desmond, P.
Ngu, M.
Angus, P.
Sinclair, M.
Meredith, C.
Matthews, G.
Revill, P.
Littlejohn, M.
Bonanzinga, S.
Bowden, D. S.
Locarnini, S.
Canchola, J.
Siew, P.
Lau, J.
La Brot, B.
Kuchta, A.
Visvanathan, K.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 49 - 49
[8] Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women
Sangfelt, P
Von Sydow, M
Uhnoo, I
Weiland, O
Lindh, G
Fischler, B
Lindgren, S
Reichard, O
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (03) : 182 - 185
[9] HBsAg Kinetics in Retreatment Decision for Off-Therapy Hepatitis B Flare in HBeAg-Negative Patients
Liaw, Yun-Fan
Jeng, Wen-Juei
Chang, Ming-Ling
GASTROENTEROLOGY, 2018, 154 (08) : 2280 - 2281
[10] HBV DNA Levels Predict Significant Liver Histology for HBeAg-Negative Chronic Hepatitis B Patients
Seto, Wai Kay
Lai, Ching-Lung
Fung, James
Yuen, John
Wong, Danny K. H.
Yuen, Man-Fung
GASTROENTEROLOGY, 2010, 138 (05) : S788 - S788

← 1 2 3 4 5 →